Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept for Chemotherapy-Induced Anemia in Metastatic Breast Cancer
NCT00931606Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jun 2009
- Primary completion
- Nov 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of sotatercept, sponsored by Merck & Co.. Started Jun 2009; status: terminated.
02
Drugs
sotatercept
Beyond the preview
Go deeper on NCT00931606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931606.